Analysts’ Opinions Are Mixed on These Healthcare Stocks: BioMarin Pharmaceutical (NASDAQ: BMRN), Globus Medical (NYSE: GMED) and Endologix (NASDAQ: ELGX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioMarin Pharmaceutical (BMRN – Research Report), Globus Medical (GMED – Research Report) and Endologix (ELGX – Research More »

Mizuho Securities Keeps Their Buy Rating on BridgeBio Pharma (BBIO)

In a report released today, Salim Syed from Mizuho Securities maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report), with a price target of $51.00. The company’s shares closed last More »